PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+65.17%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$5B
AUM Growth
+$5B
(+35%)
Cap. Flow
-$50.5M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
53.97%
Holding
139
New
30
Increased
24
Reduced
18
Closed
23
Top Buys
| 1 |
Korro Bio
KRRO
|
$49.8M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$43M |
| 3 |
Kodiak Sciences
KOD
|
$38M |
| 4 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$33.6M |
| 5 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
$23.8M |
Top Sells
| 1 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$104M |
| 2 |
Solid Biosciences
SLDB
|
$69.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$48.1M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$44.2M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$33.9M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Financials | 0.38% |
| 3 | Technology | 0.12% |
| 4 | Consumer Discretionary | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $466M | 9.26% | 5,865,726 -10,000 | -0.2% | -$795K |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $413M | 8.2% | 3,203,406 -111,200 | -3% | -$14.3M |
|
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $388M | 7.71% | 3,612,554 -447,346 | -11% | -$48.1M |
|
|
4
Kodiak Sciences
KOD
$478M
| $264M | 5.24% | 3,663,557 +528,358 | +17% | +$38M |
|
|
5
Iovance Biotherapeutics
IOVA
$807M
| $261M | 5.18% | 9,416,202 -1,598,500 | -15% | -$44.2M |
|
6
Amicus Therapeutics
FOLD
$2.34B
| $245M | 4.86% | 25,132,364 +522,664 | +2% | +$5.09M |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $193M | 3.84% | 3,709,152 +445,000 | +14% | +$23.2M |
|
|
ATNX
8
DELISTED
Athenex, Inc. Common Stock
ATNX
| $176M | 3.5% | 11,532,467 +797,222 | +7% | +$12.2M |
|
|
AMRN
9
Amarin Corp
AMRN
$311M
| $152M | 3.03% | 7,106,079 -530,000 | -7% | -$11.4M |
|
10
BridgeBio Pharma
BBIO
$9.89B
| $142M | 2.83% | 6,706,268 | – | – |
|
11
MeiraGTx Holdings
MGTX
$587M
| $129M | 2.56% | 6,433,277 | – | – |
|
|
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
| $128M | 2.55% | 3,337,522 +120,000 | +4% | +$4.62M |
|
|
QTNT
13
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $126M | 2.51% | 13,289,054 +2,500,000 | +23% | +$23.8M |
|
14
Zymeworks
ZYME
$1.12B
| $109M | 2.17% | 2,403,026 +14,136 | +0.6% | +$643K |
|
|
NVRO
15
DELISTED
NEVRO CORP.
NVRO
| $89.8M | 1.78% | 763,886 -210,887 | -22% | -$24.8M |
|
|
MYOK
16
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $87.9M | 1.75% | 1,206,411 +75,900 | +7% | +$5.53M |
|
|
KDMN
17
DELISTED
Kadmon Holdings, Inc.
KDMN
| $66.3M | 1.32% | 14,636,334 +1,470,588 | +11% | +$6.66M |
|
18
Crinetics Pharmaceuticals
CRNX
$2.92B
| $64.9M | 1.29% | 2,587,953 | – | – |
|
|
VBIV
19
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $63.4M | 1.26% | 45,951,556 | – | – |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $55.9M | 1.11% | 2,835,637 -69,363 | -2% | -$1.37M |
|
21
Verrica Pharmaceuticals
VRCA
$52.8M
| $52M | 1.03% | 3,410,412 | – | – |
|
22
Rocket Pharmaceuticals
RCKT
$354M
| $51M | 1.01% | 2,239,241 +261,829 | +13% | +$5.96M |
|
|
23
Korro Bio
KRRO
$217M
| $49.8M | 0.99% | +3,034,296 | New | +$49.8M |
|
|
BPMC
24
DELISTED
Blueprint Medicines
BPMC
| $49.6M | 0.98% | 618,624 -264,640 | -30% | -$21.2M |
|
|
DBVT
25
DBV Technologies
DBVT
$264M
| $46.7M | 0.93% | 4,367,809 +758,725 | +21% | +$8.12M |
|